Skip to main content

Advertisement

Log in

Controversies in ammonia metabolism: implications for hepatic encephalopathy

  • ORIGINAL PAPER
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Kostler H, Hecker H, Burchert W (2004). Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79

    Article  PubMed  CAS  Google Scholar 

  • Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leevy CM, Kiernan T (1985) Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 9:288–295

    PubMed  CAS  Google Scholar 

  • Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE (1979) The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254:4982–4992

    PubMed  CAS  Google Scholar 

  • Eriksson LS, Conn HO (1989) Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology 10:228–246

    Article  PubMed  CAS  Google Scholar 

  • Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127:40–47

    Article  PubMed  CAS  Google Scholar 

  • Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB (1976) The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91

    PubMed  CAS  Google Scholar 

  • Gjedde A, Lockwood AH, Duffy TE, Plum F (1978) Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge. Ann Neurol 3:325–330

    Article  PubMed  CAS  Google Scholar 

  • Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood–brain barrier. J Pharm Pharmacol 49:1211–1216

    PubMed  CAS  Google Scholar 

  • Harmar AJ, Horn AS (1976) Octopamine in mammalian brain: rapid post mortem increase and effects of drugs. J Neurochem 26:987–993

    Article  PubMed  CAS  Google Scholar 

  • Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 43:42–50

    Article  PubMed  CAS  Google Scholar 

  • Lockwood AH, McDonald JM, Reiman RE, Gelbard AS, Laughlin JS, Duffy TE, Plum F (1979) The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest 63:449–460

    Article  PubMed  CAS  Google Scholar 

  • Lockwood AH, Finn RD, Campbell JA, Richman TB (1980) Factors that affect the uptake of ammonia by the brain: the blood–brain pH gradient. Brain Res 181:259–266

    Article  PubMed  CAS  Google Scholar 

  • Lockwood AH, Yap EW, Wong WH (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337–341

    PubMed  CAS  Google Scholar 

  • Michel H, Solere M, Granier P, Cauvet G, Bali JP, Pons F, Bellet-Herman H (1980) Treatment of cirrhotic hepatic encephalopathy with L-DOPA, a controlled trial. Gastroenterology 79:207

    PubMed  CAS  Google Scholar 

  • Michel H, Bories P, Aubin JP, Pomier Layrargues G, Bauret P, Bellet Herman H (1985) Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 5:282–289

    PubMed  CAS  Google Scholar 

  • Phelps ME, Hoffman EJ, Raybaud C (1977) Factors which affect cerebral uptake and retention of 13NH3. Stroke 8:694–702

    PubMed  CAS  Google Scholar 

  • Raichle ME, Larson KB (1981) The significance of the NH3\( {\text{NH}}^{{\text{ + }}}_{{\text{4}}} \) equilibrium on the passage of 13N–ammonia from blood to brain. Circ Res 48:913–937

    PubMed  CAS  Google Scholar 

  • Sørensen M, Keiding S (2006) Response to Lockwood and Wack: The brain permeability-surface product for ammonia. Hepatology 43:1053–1056

    Article  Google Scholar 

  • Uribe M, Garcia-Ramos G, Ramos M, Valverde C, Marquez MA, Farca A, Guevara L (1983) Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy. Am J Gastroenterol 78:517–522

    PubMed  CAS  Google Scholar 

  • Wahren K, Denis J, Desurmont P, Eriksson LS, Escoffier J-M, Gauthier AP, Hagenfeldt L, Michel H, Opolon P, Paris J-C, Veyrac M (1983) Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 3:475–480

    Article  PubMed  CAS  Google Scholar 

  • Zieve L, Olsen RL (1977) Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut 18:688–691

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan H. Lockwood.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lockwood, A.H. Controversies in ammonia metabolism: implications for hepatic encephalopathy. Metab Brain Dis 22, 285–289 (2007). https://doi.org/10.1007/s11011-007-9059-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-007-9059-0

Keywords

Navigation